CD4+ T-lymphocyte nadir and the effect of highly active Antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection

被引:84
作者
Lange, CG
Valdez, H
Medvik, K
Asaad, R
Lederman, MM
机构
[1] Case Western Reserve Univ, Div Infect Dis, Dept Med, Ctr AIDS Res, Cleveland, OH 44106 USA
[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA
关键词
CD4(+) nadir; HIV; immune restoration; HAART; AIDS; lymphocyte proliferative responses; HIV p24;
D O I
10.1006/clim.2001.5164
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To evaluate the effects of the timing of highly active antiretroviral therapy (HAART) on immune reconstitution, we compared lymphocyte subpopulations and lymphocyte proliferation (LP) in response to Candida albicans, cytomegalovirus, HIV p24, Mycobacterium avium complex, pokeweed mitogen, streptokinase, and tetanus toxoid in 43 patients with pretherapy advanced, moderately advanced, and early chronic HIV-1 infection. All patients had recent CD4(+) T-cell counts greater than or equal to450/mul and HIV RNA <400 copies/ml for >12 months. CD4(+) nadirs were positively correlated with recent numbers of CD4(+) T-cells (P < 0.001), memory cells (P < 0.001), and naive CD4(+) T-cells (P < 0.05) and CD4(+) CD28(+) T-lymphocytes (P < 0.05) and were negatively correlated with recent CD8(+) T-lymphocyte counts (P < 0.05). Only CD4(+) naive T-cells normalized when HAART was initiated at lower CD4(+) T-cell levels. Fifty-three percent of patients had LP responses to HIV p24 antigen. While LP responses to prevalent antigens were usually present, responses to tetanus toxoid were more common with higher CD4(+) T-lymphocyte nadirs (P < 0.05). Delaying HAART may limit phenotypic and functional immune restoration in HIV-1 infection. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:154 / 161
页数:8
相关论文
共 40 条
  • [1] Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease
    Al-Harthi, L
    Siegel, J
    Spritzler, J
    Pottage, J
    Agnoli, M
    Landay, A
    [J]. AIDS, 2000, 14 (07) : 761 - 770
  • [2] The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1
    Altfeld, M
    Rosenberg, ES
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) : 375 - 380
  • [3] Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
    Altfeld, M
    Rosenberg, ES
    Shankarappa, R
    Mukherjee, JS
    Hecht, FM
    Eldridge, RL
    Addo, MM
    Poon, SH
    Phillips, MN
    Robbins, GK
    Sax, PE
    Boswell, S
    Kahn, JO
    Brander, C
    Goulder, PJR
    Levy, JA
    Mullins, JI
    Walker, BD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 169 - 180
  • [4] Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
    Angel, JB
    Kumar, A
    Parato, K
    Filion, LG
    Diaz-Mitoma, F
    Daftarian, P
    Pham, B
    Sun, E
    Leonard, JM
    Cameron, DW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) : 898 - 904
  • [5] Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression
    Angel, JB
    Parato, KG
    Kumar, A
    Kravcik, S
    Badley, AD
    Fex, C
    Ashby, D
    Sun, E
    Cameron, DW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) : 546 - 554
  • [6] Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years
    Arnó, A
    Ruiz, L
    Juan, M
    Zayat, MK
    Puig, T
    Balagué, M
    Romeu, J
    Pujol, R
    O'Brien, WA
    Clotet, B
    [J]. AIDS, 1998, 12 (07) : 697 - 704
  • [7] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [8] Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy
    Bart, PA
    Rizzardi, GP
    Tambussi, G
    Chave, JP
    Chapuis, AG
    Graziois, C
    Corpataux, JM
    Halkic, N
    Meuwly, JY
    Munoz, M
    Meylan, P
    Spreen, W
    McDade, H
    Yerly, S
    Perrin, L
    Lazzarin, A
    Pantaleo, G
    [J]. AIDS, 2000, 14 (13) : 1887 - 1897
  • [9] BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248
  • [10] Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution
    Blankson, JN
    Gallant, JE
    Siliciano, RF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) : 657 - 661